Product Detail
Doxorubicin Trifluoroacetate-13C,d3
Doxorubicin Stable Isotopes
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Doxorubicin
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Doxorubicin Trifluoroacetate-13C,d3 Product Information
Doxorubicin Trifluoroacetate-13C,d3 is listed under Stable Isotopes. It is associated with Doxorubicin and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-15486.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Doxorubicin Trifluoroacetate-13C,d3
CAS No.
1224610-76-7(Unlabeled)
CAT No.
CS-O-15486
Molecular Formula
C2813CH27D3F3NO13
Molecular Weight
661.56
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
OC(C(F)(F)F)=O.OC1=C(C(C2=CC=CC(O[13C]([2H])([2H])[2H])=C2C3=O)=O)C3=C(O)C4=C1C[C@](C(CO)=O)(O)C[C@@H]4O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N
IUPAC Name
(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-(methoxy-13C-d3)-7,8,9,10-tetrahydrotetracene-5,12-dione 2,2,2-trifluoroacetate
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
"Labeled Doxorubicin, intended for use as an internal standard for the quantification of Doxorubicin by GC- or LC-mass spectrometry."
Synonyms
Doxorubicin 13CD3 TFA
Application Notes
"Labeled Doxorubicin, intended for use as an internal standard for the quantification of Doxorubicin by GC- or LC-mass spectrometry."
References
"Tacar, O; Sriamornsak, P; Dass, CR, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems, The Journal of Pharmacy and Pharmacology, 2013, Feb,, 65(2): 157?70,"
